Home › Funds › Eagle Health Investments LP › ASND

Eagle Health Investments LP position in ASND

ASCENDIS PHARMA A/S · Health Care

Eagle Health Investments LP reported holding 118,629 shares of ASND (ASCENDIS PHARMA A/S) in its Q3 2026 13F filing — a position valued at US$27.0M, representing 4.87% of its reported portfolio and ranking #9 among its reported holdings. Eagle Health Investments LP has disclosed ASND holdings in 4 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)118.63K sh
Reported value held$27.03M
Portfolio Weight4.87%
First reportedQ1 2025
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Eagle Health Investments LP's ASND position evolved

Eagle Health Investments LP first disclosed a stake in ASND in Q1 2025 at 56,500 shares (US$8.8M). The position peaked in Q2 2026 at 106,158 shares, worth US$28.3M. Across 4 filings, Eagle Health Investments LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 118,629 shares valued at US$27.0M — an increase of 12,471 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 56.50K $8.81M New
Q1 2026 86.65K $19.82M New
Q2 2026 106.16K $28.31M Add
Q3 2026 118.63K $27.03M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 38 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has Eagle Health Investments LP held ASND?

Eagle Health Investments LP has disclosed ASND holdings in 4 of the last 7 reported quarters, going back to Q1 2025.

What is Eagle Health Investments LP's current position in ASND?

As of Q3 2026, Eagle Health Investments LP holds 118.63K shares of ASND (ASCENDIS PHARMA A/S), valued at $27.03M, representing 4.87% of its reported portfolio and ranking #9.

Has Eagle Health Investments LP been buying or selling ASND?

In the latest 13F filing (Q3 2026), Eagle Health Investments LP increased its position in ASND. The position peaked in Q2 2026 at 106.16K shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.